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*Corresponding Author. E-mail: john.cheek@rch.org.au.Study objective: To determine the cost-effectiveness of 3 clinical decision rules in comparison to Australian and New Zealand
usual care: the Children’s Head Injury Algorithm for the Prediction of Important Clinical Events (CHALICE), the Pediatric Emergency
Care Applied Research Network (PECARN), and the Canadian Assessment of Tomography for Childhood Head Injury (CATCH).
Methods: A decision analytic model was constructed from the Australian health care system perspective to compare costs and
outcomes of the 3 clinical decision rules compared with Australian and New Zealand usual care. The study involved multicenter
recruitment from 10 Australian and New Zealand hospitals; recruitment was based on the Australian Pediatric Head Injury Rules
Study involving 18,913 children younger than 18 years and with a head injury, and with Glasgow Coma Scale score 13 to 15 on
presentation to emergency departments (EDs). We determined the cost-effectiveness of the 3 clinical decision rules compared
with usual care.
Results: Usual care, CHALICE, PECARN, and CATCH strategies cost on average AUD $6,390, $6,423, $6,433, and $6,457 per
patient, respectively. Usual care was more effective and less costly than all other strategies and is therefore the dominant
strategy. Probabilistic sensitivity analyses showed that when simulated 1,000 times, usual care dominated all clinical decision
rules in 61%, 62%, and 60% of simulations (CHALICE, PECARN, and CATCH, respectively). The difference in cost between all rules
was less than $36 (95% conﬁdence interval –$7 to $77) and the difference in quality-adjusted life-years was less than 0.00097
(95% conﬁdence interval 0.0015 to 0.00044). Results remained robust under sensitivity analyses.
Conclusion: This evaluation demonstrated that the 3 published international pediatric head injury clinical decision rules were not
more cost-effective than usual care in Australian and New Zealand tertiary EDs. Understanding the usual care context and the
likely cost-effectiveness is useful before investing in implementation of clinical decision rules or incorporation into a guideline.
[Ann Emerg Med. 2018;-:1-11.]
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Background
Pediatric head injury is a common emergency
department (ED) presentation.1,2 Despite high prevalence,
few children have a serious outcome.3,4 Most head injuries
are mild, although some children may be at risk of
preventable adverse outcomes.5-7 Cranial computed
tomography (CT) scanning offers a sensitive method for
the identiﬁcation of intracranial injuries and is the criterion
standard investigation for the diagnosis of traumatic brain
injuries.2,7 Early identiﬁcation of traumatic brain injury can- : - 2018help avert further brain damage by directing appropriate
care.2,7 Early imaging has been associated with improved
outcomes and reduces hospital admissions by assisting in
traumatic brain injury diagnosis.2,8
Importance
There are risks of CT,1,2,4,9,10 including ionizing-
radiation-induced malignancies, to which children have
increased vulnerability.11-14 Young children may require
sedation to prevent movement, with risk of airway and
hemodynamic compromise.2,10Annals of Emergency Medicine 1
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What is already known on this topic
Pediatric head injury computed tomography (CT)
clinical decision rules have been popularized.
What question this study addressed
Are any of these clinical decision rules more cost-
effective than unstructured clinical judgment?
What this study adds to our knowledge
In this Australian and New Zealand decision analysis
model based on 18,913 injured children, the cost-
effectiveness was similar between the 3 clinical
decision rules and unstructured clinical judgment.
How this is relevant to clinical practice
In Australia and New Zealand, pediatric head CT
clinical decision rules are not more cost-effective than
unstructured clinical judgment.Rates of CT scans for the assessment of pediatric head
injury have increased considerably in recent
decades.1,7,10,11 In addition to health risks, there are cost
implications for EDs and the health care system more
broadly.
Pediatric clinical decision rules have been derived to help
clinicians make decisions concerning CT. These aim to
avoid scanning without missing traumatic brain injury and
include features of patient history and examination. Several
systematic reviews2,8,11 indicate that the most sensitive are
the Children’s Head Injury Algorithm for the Prediction of
Important Clinical Events (CHALICE),4 the Pediatric
Emergency Care Applied Research Network (PECARN)
rule1 and the Canadian Assessment of Tomography for
Childhood Head Injury (CATCH).10
The foci of the 3 clinical decision rules are different9 and
triggers for CT use vary across different settings.12 A recent,
prospective, multicenter cohort study in Australia and New
Zealand determined that the PECARN clinical decision
rule had higher point sensitivity than CATCH and
CHALICE in a cohort of children with mild head injuries
(although they had overlapping conﬁdence intervals).3
Goals of This Investigation
We determined the cost-effectiveness of the 3 clinical
decision rules compared with usual care in Australia and
New Zealand EDs in the evaluation of children with head
injury, in a single study population, to guide funding and
treatment decisions. The primary outcome is expressed asAnnals of Emergency Medicinequality-adjusted life-years incorporating traumatic brain
injury and radiation-induced cancer effects.MATERIALS AND METHODS
Study Design and Setting
Decision analytic health economic modeling was
undertaken to compare costs, outcomes, and cost-
effectiveness of the 3 clinical decision rules compared with
Australasian usual care, using standard economic evaluation
methods.13 Clinical outcomes and probabilities were based
on the Australasian Pediatric Head Injury Rules Study
(APHIRST),3,9 a multicenter prospective observational
study involving 20,137 children presenting with head
injuries to 9 tertiary pediatric EDs and one mixed ED
across Australia and New Zealand.14 APHIRST externally
evaluated the performance accuracy of the 3 clinical
decision rules.3,9
Selection of Participants
Children were enrolled in APHIRST if they presented to
a participating ED between April 11, 2011, and November
30, 2014, and were younger than 18 years and had a head
injury. Exclusion criteria were trivial facial injury only,
patients referred from ED triage to an external provider,
neuroimaging before transfer to a study site, or did not wait
to be medically reviewed.3,9 This analysis was performed on
the APHIRST comparison cohort of 18,913 patients
(93.9% of the evaluable cohort) who all had a Glasgow
Coma Scale score of 13 to 15 and presented within 24
hours of injury. This cohort represents the group of
children who create the greatest dilemma for clinicians, and
consequently for whom a clinical decision rule is most
likely to be followed. APHIRST patient characteristics are
reported in Table 1.
Interventions
The decision analytic economic model was developed in
TreeAge Pro (version 2016; TreeAge Software Inc.,
Williamstown, MA). The model compares the 3 clinical
decision rules and Australasian usual care (Figure 1). The
usual care strategy was deﬁned as management by clinicians
according to current, unstandardized, local practice in
Australia and New Zealand, which does not follow any one
speciﬁc clinical decision rule but may include knowledge
derived from the rules more broadly. In our study cohort,
the prevalence of clinically important traumatic brain
injury (a composite outcome ﬁrst published in PECARN
and previously used to compare head injury clinical
decision rules1,3) was 0.8% (160/18,913), and 0.1% (24/
18,913) required neurosurgery. Baseline CT scanning ratesVolume -, no. - : - 2018
Table 1. Characteristics of the APHIRST comparison cohort.
Demographics
APHIRST Comparison
Cohort (n[18,913)
Mean age (SD), y 5.7 (4.6)
Patients <2 y 5,046 (26.7)
Female patients 6,840 (36.2)
Presenting signs and symptoms
Headache 3,785 (20.0)
History of vomiting 3,094 (16.4)
Witnessed disorientation 2,425 (12.8)
Known or suspected loss of consciousness 2,468 (13.1)
History of amnesia* 1,591 (8.4)
Mechanism of head injury
Fall related 13,337 (70.5)
Head hit by high-impact object or projectile 1,228 (6.5)
Motor vehicle crash 745 (3.9)
Suspected nonaccidental injury 81 (0.4)
Data are presented as No. (%) unless otherwise indicated.
*Does not include preverbal children.
Dalziel et al Cost-effectiveness Analysis Comparing Clinical Decision Rulesare 8.3% of pediatric ED presentations with suspected head
injury. Clinicians were not restricted from using a clinical
decision rule, but during recruitment none of the study
institutions had formal processes in place for their use.12
Clinical management and probabilities for usual care tests
and hospitalizations were based on observed APHIRST
data. For the 3 clinical decision rules, probabilities were
derived by applying the rules based on indicated computer
algorithms, without the addition of clinical judgment. All
18,913 children were used for the assessment of each
clinical decision rule to most closely resemble an actual
clinical application in which front-line clinicians would not
usually be aware of all rule-speciﬁc inclusion and exclusion
criteria. Patients were assessed by the clinical decision
rules as being at high and low risk according to algorithms
and then compared with actual observed outcomes to
determine the number of correctly identiﬁed and missed
brain injuries. This constitutes a pragmatic approach to
modeling and compares the rules in a broad and inclusive
patient population.
The CHALICE clinical decision rule recommends a
dichotomous course of action. If one or more predictor
characteristics are present, then a CT is indicated.2,4
Similarly, the CATCH clinical decision rule recommends a
CT if one or more predictor characteristics are present,
even though the article in which the rule was derived
separated risk factors into high and medium risk.2,10 The
PECARN clinical decision rule recommends not to
conduct CT in the absence of predictor variables; however,Volume -, no. - : - 2018in their presence clinician discretion and observation are
used to determine CT use.1,2
An adjustment has been developed previously and
includes “CT recommended,” “observation versus CT
on the basis of other clinical factors,” and “CT not
recommended.”1 Essentially, the algorithm categorizes
patients as being at low, intermediate, or high risk. To
provide consistency between rule comparisons, as a
pragmatic means of modeling patients intermediate-risk
patients were recategorized as being at high risk
(observation followed by CT) in the presence of 2 or more
intermediate-risk PECARN variables, or low risk
(observation followed by no CT) if they had none or one
intermediate-risk PECARN variable. This reﬂects the
suggested actions in the PECARN algorithm1 and a
necessary assumption also used in the previously published
cost-effectiveness analysis of the PECARN clinical decision
rule. Alternative scenarios were evaluated in sensitivity
analyses that represent the upper and lower bounds of the
effect of allocating all intermediate-risk patients to receive
observation followed by CT or observation followed by
no CT (Table 2).
The economic model took a lifetime horizon, and both
the economic and health care payer perspective comprised
the Australian health care system (all hospitals in the study
are government funded). The main assumption was that any
patient categorized as being at low risk for a traumatic brain
injury did not receive a CT and that high-risk children did
immediately. In addition, CT scan is the criterion standard
and a very accurate diagnostic tool for identiﬁcation of
structural pediatric head injury. APHIRST outcome
measures focused on traumatic brain injury and
neurosurgery when a CT was required and shown to have
positive (abnormal) ﬁndings. Our study assumed CT was
therefore 100% sensitive and speciﬁc for the purpose of the
modeling, as have other published economic evaluations.2,15
It was assumed that patients categorized as being at low risk
(no CT) were discharged home, with the types and lengths
of hospital observation and intervening management as
recorded in APHIRST. Low-risk patients with missed
traumatic brain injuries were assumed to re-present to the
hospital (additional ED presentation and a CT).
Outcome Measures
Performance accuracy and clinical outcomes for applying
the CATCH, CHALICE, and PECARN clinical decision
rules versus usual care for APHIRST have been previously
reported3 but are presented here in the format used for the
economic evaluation (Table 2).
Patient outcomes after traumatic brain injury were
estimated by applying the criterion standard GlasgowAnnals of Emergency Medicine 3
Emergency 
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PECARN rule
CATCH rule
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Low risk of intracranial 
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No TBI
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Figure 1. Economic model (abbreviated). The decision tree shown for usual care is repeated for the CATCH, CHALICE, and PECARN
CDRs. CDR, Clinical decision rule; ciTBI, clinically important traumatic brain injury; neurosurgical, ciTBI that requires neurosurgical
intervention; nonneurosurgical, ciTBI that does not require neurosurgical intervention; GOS-E Peds outcome, Glasgow Outcome
Scale–Extended Pediatrics score; TBI, traumatic brain injury.
Cost-effectiveness Analysis Comparing Clinical Decision Rules Dalziel et alOutcome Scale–Extended Pediatric, consisting of levels 1
to 8.16 Transition probabilities from each injury state were
based on clinical data for the subset of patients from the
APHIRST cohort at the Royal Children’s Hospital in
Melbourne who sustained traumatic brain injuries (n¼39).
After reviewing medical records, a senior ED clinician
(J.A.C.) categorized each patient with the Glasgow
Outcome Scale–Extended Pediatric. Probabilities were then
calculated for different combinations of risk (high or low)
and outcome. Patients who did not sustain a traumatic
brain injury in either the high- or low-risk groups were
assumed to be in full health and were allocated to the
highest category, upper good recovery.
Glasgow Outcome Scale–Extended Pediatric utility
weights have been previously mapped,17 and these values
were included in the economic model (Table E1, available
online at http://www.annemergmed.com). For patients
who sustained brain injuries (clinically important traumatic4 Annals of Emergency Medicinebrain injury with or without neurosurgery) but were missed
by either the clinical decision rule or usual care, a utility
decrement of 10% was applied to reﬂect a worse outcome
through delayed treatment. Utility values were discounted
at 5% per annum, as per Australian convention.18
The estimated cancer risk of 0.12 and the quality-of-life
decrement from a single cranial CT scan of 0.0130 were
used according to the results for aged 5 and aged 4 to 9
years, respectively, of a meta-analysis conducted by Stein
et al19 (Table E1, available online at http://www.
annemergmed.com).
Resource costs and associated probabilities are listed in
Table 3. All costs are reported in 2016 Australian dollars, and
earlier data were inﬂated by using the general consumer price
index from the Reserve Bank of Australia (July 20, 2017) in
accordance with current economic evaluation guidance.20
An assumed 10% loading, or additional cost, was
applied to costs for children whose traumatic brain injuryVolume -, no. - : - 2018
Table 2. Comparison of application of clinical decision rules to APHIRST data for economic evaluation: numbers indicated for CT scan and
numbers of clinically important traumatic brain injuries identiﬁed and missed.
Outcome Measures
Base Case Analysis Sensitivity Analysis for PECARN
Usual Care PECARN CATCH CHALICE
Intermediate
Allocated to
Low Risk*
Intermediate
Allocated to
High Risk†
High risk (received cranial CT scan), No. (%) 1,579 (8.3) 3,324 (17.6) 5,707 (30.2) 4,166 (22.0) 1,808 (9.6) 8,812 (46.6)
ciTBI, neurosurgical 24 21 23 22 18 24
ciTBI, nonneurosurgical 134 120 124 126 102 135
No TBI 1,421 3,183 5,560 4,018 1,688 8,653
Low risk (no cranial CT scan), No. (%) 17,334 (91.7) 15,589 (82.4) 13,206 (69.8) 14,747 (78.0) 17,105 (90.4) 10,101 (53.4)
Missed ciTBI, neurosurgical 0 3 1 2 6 0
Missed ciTBI, nonneurosurgical 2 16 12 10 34 1
No TBI 17,332 15,570 13,193 14,735 17,065 10,100
*Patients considered to be at intermediate risk of head injury were allocated to the low-risk group (no CT indicated).
†Patients considered to be at intermediate risk of head injury were allocated to the high-risk group (CT indicated).
Dalziel et al Cost-effectiveness Analysis Comparing Clinical Decision Rules(with or without neurosurgery) was missed on initial
presentation to account for the likely greater severity
attached to an injury that was initially missed compared
with the same injury treated immediately.Primary Data Analysis
The economic evaluation results are presented as a cost
per quality-adjusted life-years gained because of traumatic
brain injury (short- and long-term management and care)
and radiation-induced cancers for the usual care group
compared with the 3 clinical decision rules. Incremental
cost-effectiveness ratios were calculated to compare each
strategy with usual care (difference in costs divided by
difference in quality-adjusted life-years). Multiple
comparisons of the 3 clinical decision rules were made
according to published reporting guidance.20 Results are
reported according to the Consolidated Health Economic
Evaluation Reporting Standards guideline.21 Statistical
preparation of original data was performed with Stata
(version 14.0; StataCorp, College Station, TX).Sensitivity Analyses
Probabilistic sensitivity analysis using 1,000 simulations
was conducted to investigate the effect of parametric
uncertainty (see Table 4, Figure 2, and Tables EXXXX
[available online at http://www.annemergmed.com] for
parameters and distributions). The 95% conﬁdence
intervals for utility and cost decrements (Tables EXXXX,
available online at http://www.annemergmed.com) for
missed brain injuries, costs of CT, probability of cancer,
Glasgow Outcome Scale–Extended Pediatric utility values,Volume -, no. - : - 2018other hospital costs, utility decrement of cancer, cancer cost
and Glasgow Outcome Scale–Extended Pediatric costs were
used in one-way sensitivity analyses, along with various
discount rates (3.5% and 6%) and various cancer latency
periods (5 and 20 years).RESULTS
Usual care, CHALICE, PECARN, and CATCH
strategies cost on average AUD $6,390, $6,423, $6,433,
and $6,457 per patient, respectively (Table 4). The CT
scanning rates were 8.3% for usual care, 17.6% for
PECARN, 22.0% for CHALICE, and 30.2% for CATCH.
From an Australian health care system perspective, the
usual care strategy was more effective in detecting traumatic
brain injuries and used fewer CT scans. The magnitude of
differences in cost and quality-adjusted life-years between
the clinical decision rules was small. Usual care was more
effective and the least costly and therefore dominated all
other strategies. When multiple comparisons of clinical
decision rules were made, CHALICE was mostly likely to
be cost-effective. The cost-effectiveness results are
presented in Table 4.
Sensitivity analysis showed that when intermediate-risk
PECARN patients were allocated to low risk, this rule
became closer in cost to usual care, but less effective
(because of reduced CT scanning with a greater number of
missed injuries). Under this scenario, usual care remained
dominant. When intermediate-risk PECARN patients were
moved to high risk, this rule became costlier (more CTs)
and more effective; however, usual care remained
dominant. The model is sensitive to the reallocation ofAnnals of Emergency Medicine 5
Table 3. Immediate and long-term costs used in the economic model for each health state.
Immediate Costs* Abbreviation Mean (95% CI, SE), $ Distribution Source
ED presentation (ED) cED 380 (372–388, 4) g† Hospital cost data‡
Emergency SSU cSSU 459 (396–522, 32) g Hospital cost data‡
Inpatient stay, general ward cWard 2,886 (2,715–3,057, 87) g Hospital cost data‡
Inpatient stay, ICU cICU 45,694 (37,160–54,228, 4,354) g Hospital cost data‡
Cranial CT scan cCT 290§ (5.80–574) g Australian Government, (2017)27
Intubationk cIntubation 283§ (5.66–560) g Tvede et al (2012)28
Neurosurgery cNeurosurgery 3,702 (3,341–4,063, 184) g Hospital cost data‡
Health state Summary of resources used
Assessed as high risk and received a CT scan
ciTBI, neurosurgical cEDþcCTþcNeurosurgeryþ(cIntubationpIntubation)þ(pAttendancecSSU, cWard, cICU)
ciTBI, nonneurosurgical cEDþcCTþ(cIntubationpIntubation)þ(pAttendancecSSU, cWard, cICU)
No TBI cEDþcCTþ(pAttendancecSSU, cWard, cICU)
Assessed as low risk and did not receive CT scan initially
Missed ciTBI, neurosurgical Initial costs: cEDþ(pAttendancecSSU, cWard, cICU)
Re-presentation costs: cEDþcCTþ(cIntubationpIntubation)þcNeurosurgeryþ(pAttendance
cSSU, cWard, cICU)10% loading
Missed ciTBI, nonneurosurgical Initial costs: cEDþ(pAttendancecSSU, cWard, cICU)
Re-presentation costs: cEDþcCTþ(cIntubationpIntubation)þ(pAttendancecSSU, cWard,
cICU)10% loading
No TBI cEDþ(pAttendancecSSU, cWard, cICU)
Probabilities Abbreviation Probability Distribution Source
Intubation pIntubation 0.0083 b Original patient data from
Nishijma et al (2014)15
Attendance pAttendance¼pSSUþ
pWardþpICU
Neurosurgical ciTBI§¼0.083þ1.0þ0.292
Nonneurosurgical ciTBI¼0.067þ0.941þ0.081
No TBI¼0.759þ0.247þ0.0093
b Babl et al (2017)3
Long-term costs Variable name Mean (95% CI, SE), $ Distribution Source
Cost of care for GOS-E state 2 cGOS-E2:
year 1
Year 2 onward
343,495§ (6,870–680,120)
55,362 (5,166–511,408, 133,981)
g Fields et al, (2003)29k
Cost of care for GOS-E state 3 cGOS-E3 80,976§ (1,620–160,332) g Beecham et al (2009)30
Cost of care for GOS-E state 4 cGOS-E4 42,235§ (845–83,625) g Beecham et al (2009)30
Cost of cancer{ cCancer 35,030 (19,826–50,234, 7,757) g Adult hospital cost data#
CI, Conﬁdence interval; SSU, short-stay unit.
*Costs of the ED are based on average triage times in the cubicle and are reported in minutes: level 2¼231 (SD 150), level 3¼180 (SD 142), level 4¼136 (SD 100), and level
5¼98 (SD 98). The SSU had an average time of 1.03 days (SD 0.34).
†A g distribution was chosen for costing data to reﬂect their skewed nature.
‡ED, SSU, and inpatient cost data were drawn from the individual patient level 2013 to 2014 ﬁnancial data for the APHIRST patients at a specialist pediatric hospital in
Melbourne, Australia. Admitted episodes were for children aged 0 to 18 years and presenting with International Classiﬁcation of Diseases, 10th Revision (ICD-10) codes indicating
head injury (ICD-10 S00-S16 and T20).
§In the absence of reported data on measures of variance, the SEs are assumed to be half the mean.
kCost data taken from literature have been converted to Australian dollars and inﬂated to 2016 values with Reserve Bank of Australia ﬁgures from February 13, 2018.
{Costs of cancer were applied in the economic model during a 5-year period, with a 10-year latency period assumed.
#Based on 481 episodes of care in 2014 and 2015 for 55 patients presenting to a specialist cancer center in Melbourne, Victoria, with a primary diagnosis of high-grade glioma.
Cost-effectiveness Analysis Comparing Clinical Decision Rules Dalziel et alintermediate-risk PECARN patients, but under neither
scenario is PECARN likely to be cost-effective or preferred
according to economic evaluation results.
The results of probabilistic sensitivity analyses are
presented in Table 4 and Figure 2A and show that for 61%,6 Annals of Emergency Medicine62%, and 60% of simulations, usual care is dominant
compared with CATCH, CHALICE, and PECARN,
respectively. The cost-effectiveness acceptability curve
(Figure 2B) shows that for a willingness to pay of $50,000
per quality-adjusted life-year gained, more than 70% of theVolume -, no. - : - 2018
Table 4. Economic evaluation results, each strategy compared with usual care, head-to-head comparison of clinical decision rules, and
PECARN alternate allocation to low- and high-risk groups (per child presenting to the ED).
Mean Cost, $ Mean QALYs ICER, $
Economic comparison of each clinical decision rule with usual care
Usual care vs 6,390 16.97686 Dominant* strategy
PECARN 6,423 16.97567 Dom
CHALICE 6,433 16.97604 Dom
CATCH 6,457 16.97581 Dom
Comparison of multiple CDRs†
PECARN vs 6,423 16.97595 22,727‡
CHALICE 6,433 16.97639
Sensitivity analysis, economic comparison of allocating intermediate-risk PECARN patients to low- and high-risk groups with usual care
PECARN (low)§ vs usual care 6,408
6,390
16.97464
16.97686
Dom
Dominant strategy
PECARN (high)k vs usual care 6,500
6,390
16.97706
16.97686
550,000{
Probabilistic sensitivity analysis: each rule compared with usual care
Usual care vs 6,431 (2,690) 16.97706 (0.0060) Dominant strategy
CHALICE 6,467 (2,668) 16.97681 (0.0061) Dom
PECARN 6,461 (2,714) 16.97693 (0.0064) Dom
CATCH 6,465 (2,656) 16.97680 (0.0061) Dom
QALY, Quality-adjusted life-year; ICER, incremental cost-effectiveness ratio, cost per QALY gained; DOM, dominated strategy (more costly and less effective).
*“Dominant” refers to a strategy’s being less costly and more effective and therefore preferred.
†Note that CATCH is excluded from the multiple comparison of CDRs because of being dominated by the other CDRs (more expensive and less effective).
‡CHALICE is likely cost-effective for a threshold of less than $50,000 per QALY gained.
§All intermediate-risk PECARN patients according to CDR were reallocated to the low-risk modeling group for analysis.
kAll intermediate-risk PECARN patients according to CDR were reallocated to the high-risk modeling group for analysis.
{PECARN (high) is unlikely to be cost-effective with a threshold of less than $50,000 per QALY gained.
Dalziel et al Cost-effectiveness Analysis Comparing Clinical Decision Rulessimulations indicate usual care as the preferred strategy.
Cost-effectiveness results remained robust to a number of
sensitivity analyses performed (Figure 3). The usual care
strategy remained the dominant strategy under all
sensitivity analyses performed. The economic model was
most sensitive to the number and cost of cranial CTs, the
method for allocation of PECARN intermediate patients,
the probability of cancer, and the rate at which future
outcomes and costs are discounted. The model trades off
the loss of utility and increased costs associated with missed
head injuries against the additional cost of imaging. For
example, a scenario in which no patients are given a CT
leads to a lower price compared with usual care but also
fewer quality-adjusted life-years and is not likely cost-
effective.
LIMITATIONS
This evaluation has several limitations. Cost data from
a single center may limit generalizability of results.
Nevertheless, results remained robust under sensitivity
analyses when cost inputs were varied (Figure 3) and theVolume -, no. - : - 2018same cost data were applied to usual care and all 3 clinical
decision rules. The usual care strategy involves additional
periods of patient observation, which are associated with an
opportunity cost for another patient who may have been
treated in that cubicle or bed in the previous patient’s place.
The cost of the ED and short stay unit is based on minutes
in the cubicle or bed and is incorporated, but additional
beneﬁts to another patient are not included. Long-term
outcomes for children with neurosurgical traumatic brain
injuries were based on a small sample of 39 children from
APHIRST; however, the model was not overly sensitive to
these utility values. The ability to use original data from the
same study to inform the distribution of longer-term
outcomes for the economic evaluation could be considered
a strength compared with other published economic
evaluations that rely on secondary data from a different
sample.15,22
Treating physicians collected information on all clinical
decision rule predictor variables, and it is possible that the
collection of data inﬂuenced decisionmaking. This may
have led to increased effectiveness and therefore cost-Annals of Emergency Medicine 7
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Figure 2. A, Sensitivity analysis and B, cost-effectiveness acceptability curve comparing clinical decision rules.
Cost-effectiveness Analysis Comparing Clinical Decision Rules Dalziel et aleffectiveness of the usual care strategy. However, the overall
rate of CT use in the prospective APHIRST study is
consistent with a previous retrospective report in the same
setting.5,23
Although we did not ﬁnd systematic or large-scale use of
clinical decision rules, according to a survey we conducted
across the PREDICT network before the study,12 clinicians
may have used one or all of the rules for their individual8 Annals of Emergency Medicinedecisionmaking. It remains possible that usual care includes
principles from the clinical decision rules gathered through
training and practice and that the clinical decision rules
represent formal or informal supplements to care.
However, widespread use any of the rules should have
increased the usual care CT rate over the known long-term
stable prestudy baseline; this did not happen. A further
limitation relates to the inclusion of clinical discretion inVolume -, no. - : - 2018
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Figure 3. Results of one-way sensitivity analyses showing difference in cost per quality-adjusted life-year from base case for CATCH,
CHALICE, and PECARN compared with usual care.
Dalziel et al Cost-effectiveness Analysis Comparing Clinical Decision Rulesthe usual care strategy but not for clinical decision rule
strategies, which is inevitable, given the data source. In
practice, clinical decision rules are always implemented
with clinical discretion.3,23 There could be signiﬁcant
variation of usual practices across the 10 sites. The usual
care group demonstrates that high-quality decisions are
being made by clinicians, but further research using the
APHIRST data set would be needed to quantitatively
describe usual care.
The rules were applied in a pragmatic manner in which
all children in the comparison cohort were made eligible for
assessment with each clinical decision rule. The APHIRST
cohort assessed with each rule is therefore different from
the cohorts in the derivation studies that maintained varied
eligibility criteria. This could affect the performance
accuracy of the clinical decision rules. However, this
method constitutes a real-world approach and may reﬂect
the practices and population in which the rules will be
implemented. The economic model relies on a computer
algorithm applied to data, and in actual practice clinician
judgment would play a signiﬁcant role. Additionally, the
PECARN rule was developed to allow clinician discretion
(in regard to observation for intermediate-risk patients1),
and in applying PECARN to the data set we have no way
of including this. In an actual application of the clinical
decision rules, in particular the PECARN rule, all of these
factors may result in different probabilities than thoseVolume -, no. - : - 2018imputed, which could affect results. We carefully varied the
assumptions around the allocation of PECARN
intermediate-risk patients to high- and low-risk categories
to assess the effect of this assumption.
DISCUSSION
This economic evaluation for the ﬁrst time, to our
knowledge, directly compares the cost-effectiveness of 3
clinical decision rules and Australasian usual care for the
assessment of pediatric head injuries presenting to EDs.
The results of the economic modeling demonstrate that the
3 published head injury clinical decision rules are not more
cost-effective than Australian and New Zealand usual care
strategy. The absolute differences between the rules were
small, with the largest difference in bootstrapped cost of
$36 (95% conﬁdence interval –$7 to $77) and 0.00097
(95% conﬁdence interval 0.0015 to 0.00044) quality-
adjusted life-years per child (equating to an additional 8.5
hours of quality-adjusted life). The cost-effectiveness results
were robust under all one-way and probabilistic sensitivity
analyses. It is therefore unlikely in this patient setting that
the economic evaluation results would suggest the use of
any speciﬁc clinical decision rule over another.
The strengths of the analysis include a large data set, the
use of multiple centers, and that the analysis was able to
compare the rules hypothetically using standardized
modeling techniques and assumptions.Annals of Emergency Medicine 9
Cost-effectiveness Analysis Comparing Clinical Decision Rules Dalziel et alThe clinical decision rules were derived to optimize the
balance between identifying signiﬁcant brain injuries and
minimizing the exposure of the developing brain to
radiation. However, the results presented here do not
indicate high value in investing in strategies to switch from
usual care, or from one rule to another in our setting. In
comparison, a cost-effectiveness analysis conducted in the
United States by Nishijima et al15 reported that PECARN
was the dominant strategy compared with usual care
(characterized by a 33.8% CT rate).15 Another cost-
effectiveness analysis, conducted in the United Kingdom by
Holmes et al,22 investigated CHALICE and PECARN and
demonstrated that both are a cost-effective approach. The
comparators for this study were not usual practice, but
theoretical: CT for all patients and discharge all without
testing. It is possible that implementing clinical decision
rules in countries where the baseline CT rate is signiﬁcantly
higher than the 8.3% scanning rate in Australia and New
Zealand will lead to more advantageous cost-effectiveness
ratios. Interventions to appropriately reduce existing
imaging rates are likely to be more cost-effective in countries
known to have higher unit costs of health care such as the
United States. It is likely that patterns of usual care are
critical to the choice of clinical decision rule. Initiatives such
as Choosing Wisely,24-26 which aim to inform evidence
based on cost-effective practice choices, should more fully
account for usual care contexts when making
recommendations. Australian and New Zealand usual care
remained cost-effective, indicating no economic imperative
for investing in change. We failed to observe important
differences in cost or effectiveness between the rules,
indicating a lack of economic imperative for switching from
any rule to another. Other important factors to the decision
are likely to include physician experience and rule-speciﬁc
sensitivities and speciﬁcities for outcomes, which were not
considered in this economic evaluation. The use of clinical
decision rules outside of specialist pediatric hospitals or by
clinicians who are less experienced in evaluating children
may generate different results.
In summary, the practice of usual care in our setting is
an effective strategy and is cost saving. Compared with
usual care in the Australasian specialized pediatric hospital
setting, the CATCH, CHALICE, and PECARN clinical
decision rules are all projected to scan more children and
may miss more neurosurgical and nonneurosurgical
traumatic brain injuries that are likely to result in increased
hospital costs, with a potential reduction in positive health
outcomes. These results were robust under several one-way
and probabilistic sensitivity analyses. Further analysis is
required to provide a comprehensive deﬁnition about what
usual care constitutes. This evaluation highlights the10 Annals of Emergency Medicineimportance of understanding usual practice before
investing in the implementation of international clinical
decision rules derived within other health care settings and
countries.
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